We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

medicine×マーケットリサーチセンター - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

106~120 item / All 449 items

Displayed results

[Research Material] The Global Market for Atrophic Gastritis Treatment

Global Market for Atrophic Gastritis Treatment: Coatings, Antibiotics, Vitamin B-12, Hospital Pharmacies, Retail Pharmacies, Drugstores, Online Pharmacies

This research report (Global Atrophic Gastritis Treatment Market) investigates and analyzes the current state and outlook for the global market for atrophic gastritis treatment over the next five years. It includes information on the overview of the global atrophic gastritis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the atrophic gastritis treatment market focus on coating agents, antibiotics, and vitamin B-12, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and online pharmacies. The regional segments calculate the market size for atrophic gastritis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in atrophic gastritis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Castleman Disease Treatment

Global Market for Castleman Disease Treatment: Monoclonal Antibodies, Chemotherapy, Radiation Therapy, Immunotherapy, Corticosteroids, Antiviral Drugs, Disease ...

This research report (Global Castleman Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for Castleman disease treatment over the next five years. It includes information on the overview of the global Castleman disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Castleman disease treatment market include monoclonal antibodies, chemotherapy, radiation therapy, immunotherapy, corticosteroids, and antiviral drugs, while the segments by application focus on hospitals, clinics, and outpatient units. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Castleman disease treatment. It also includes the market share of major companies in Castleman disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Antifungal Drugs for Dermatophyte Nail Infections (DOT)

World Market for Antifungal Drugs for Dermatophyte Nail Infections: Topical, Oral Therapy, Hospitals, Dermatology and Podiatry Clinics, Independent Pharmacies, Mail-Order Pharmacies, Drugstores

This research report (Global Dermatophytic Onychomycosis Therapeutics (D)) investigates and analyzes the current status and outlook for the global market of dermatophytic onychomycosis therapeutics (DOT) over the next five years. It includes information on the overview of the global dermatophytic onychomycosis therapeutics (DOT) market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for dermatophytic onychomycosis therapeutics (DOT) by type focus on topical and oral therapies, while the segments by application target hospitals, dermatology and podiatry clinics, independent pharmacies, mail-order pharmacies, and drugstores. The regional segments calculate the market size of dermatophytic onychomycosis therapeutics (DOT) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in dermatophytic onychomycosis therapeutics (DOT), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Gaucher Disease (GD) Treatments

Global Market for Gaucher Disease (GD) Treatments: Enzyme Replacement Therapy, Substrate Reduction Therapy, Non-Neuropathic Gaucher Disease, Neuropathic Gaucher Disease

This research report (Global Gaucher Disease (GD) Drugs Market) investigates and analyzes the current status and future outlook of the global market for Gaucher disease (GD) treatment drugs over the next five years. It includes information on the overview of the global Gaucher disease (GD) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Gaucher disease (GD) treatment drugs by type include enzyme replacement therapy and substrate reduction therapy, while the segments by application focus on non-neuropathic Gaucher disease and neuropathic Gaucher disease. The regional segments calculate the market size for Gaucher disease (GD) treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the Gaucher disease (GD) treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment

Global Market for Non-Alcoholic Steatohepatitis (NASH) Treatment: Off-Label, Therapeutics, Hospital Pharmacies, Online Providers, Retail Pharmacies

This research report (Global Non-Alcoholic Steatohepatitis (NASH) Treatment) investigates and analyzes the current status and outlook for the global market for non-alcoholic steatohepatitis (NASH) treatment over the next five years. It includes information on the overview of the global non-alcoholic steatohepatitis (NASH) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for non-alcoholic steatohepatitis (NASH) treatment by type focus on off-label and therapeutic drugs, while the segments by application target hospital pharmacies, online providers, and retail pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for non-alcoholic steatohepatitis (NASH) treatment. It also includes the market share of major companies in non-alcoholic steatohepatitis (NASH) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Antimicrobial Treatment

Global Market for Antimicrobial Therapy: Penicillin, Cephalosporins, Quinolones, Aminoglycosides, Monobactams, Carbapenems, Macrolides, ...

This research report (Global Antibacterial Therapeutic Market) investigates and analyzes the current state of the global antibacterial therapeutic market and its outlook for the next five years. It includes information on the overview of the global antibacterial therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the antibacterial therapeutic market include penicillin, cephalosporins, quinolones, aminoglycosides, monobactams, carbapenems, macrolides, and others, while the segments by application cover oral, topical, non-oral, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for antibacterial therapeutics. It also includes the market share of major companies in antibacterial therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Scleroderma Treatment Solutions

Global Market for Scleroderma Treatment Solutions: Immunotherapy, Antifibrotic Drugs, Others, Hospitals, Clinics, Others

This research report (Global Scleroderma Therapy Solutions Market) investigates and analyzes the current status and outlook for the global market for scleroderma treatment solutions over the next five years. It includes information on the overview of the global scleroderma treatment solutions market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunotherapy, anti-fibrotic drugs, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for scleroderma treatment solutions. It also includes the market share of major companies in the scleroderma treatment solutions sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Acute Heart Failure (AHF) Treatment Drugs

World Market for Acute Heart Failure (AHF) Treatment Drugs: Beta-blockers, Calcium Channel Blockers, Cardiac Glycosides, Diuretics, Morphine, Vasodilators/Nitrates ...

This research report (Global Acute Heart Failure (AHF) Therapeutics Market) investigates and analyzes the current status and outlook for the global market of acute heart failure (AHF) therapeutics over the next five years. It includes information on the overview of the global acute heart failure (AHF) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, cardiac glycosides, diuretics, morphine, vasodilators/nitrates, and others, while the segments by application focus on hospitals, clinics, and home care. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for acute heart failure (AHF) therapeutics. It also includes the market share of major companies in the acute heart failure (AHF) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Psoriatic Arthritis Treatments

World Market for Psoriatic Arthritis Treatments: Non-Steroidal Anti-Inflammatory Drugs, Disease-Modifying Anti-Rheumatic Drugs, Biological Agents, Enzyme Inhibitors, Hospitals, Clinics, Laboratories

This research report (Global Psoriatic Arthritis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for psoriatic arthritis therapeutics over the next five years. It includes information on the overview of the global psoriatic arthritis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biological agents, and enzyme inhibitors, while the segments by application focus on hospitals, clinics, and laboratories. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for psoriatic arthritis therapeutics. It also includes the market share of major companies in the psoriatic arthritis therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Sodium Lauryl Sulfate

World Market for Sodium Lauryl Sulfate: Gastrointestinal and Metabolic Sodium Lauryl Sulfate, Constipation Treatment Sodium Lauryl Sulfate ...

This research report (Global Sodium Lauryl Sulfoacetate Market) investigates and analyzes the current status and outlook for the global sodium lauryl sulfoacetate market over the next five years. It includes information on the overview of the global sodium lauryl sulfoacetate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include gastrointestinal and metabolic sodium lauryl sulfoacetate, constipation treatment sodium lauryl sulfoacetate, and enema sodium lauryl sulfoacetate. The segments by application focus on human health, emergency medical services, laboratories, animal toxicity, and metabolism/pharmacokinetics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of sodium lauryl sulfoacetate. It also includes the market share of major companies in sodium lauryl sulfoacetate, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Systemic Psoriasis Treatments

Global Market for Systemic Psoriasis Treatments: Biologics, Small Molecules, Mild Psoriasis, Moderate Psoriasis, Severe Psoriasis

This research report (Global Systemic Psoriasis Therapeutics Market) investigates and analyzes the current status and outlook for the global market of systemic psoriasis therapeutics over the next five years. It includes information on the overview of the global systemic psoriasis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on biologics and small molecules, while the segments by application target mild psoriasis, moderate psoriasis, and severe psoriasis. The regional segments calculate the market size of systemic psoriasis therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in systemic psoriasis therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Anti-Obesity Therapies

Global Market for Anti-Obesity Therapies: Centrally Acting Anti-Obesity Drugs, Peripherally Acting Anti-Obesity Drugs, Hospital Use, Clinic Use, Home Use, Others

This research report (Global Anti-Obesity Therapeutics Market) investigates and analyzes the current state and outlook for the global anti-obesity therapeutics market over the next five years. It includes information on the overview of the global anti-obesity therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-obesity therapeutics market focus on centrally acting anti-obesity drugs and peripherally acting anti-obesity drugs, while the segments by application target hospitals, clinics, home use, and others. The regional segments calculate the market size for anti-obesity therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in anti-obesity therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Chlorhexidine Gluconate Solution

Global Market for Chlorhexidine Gluconate Solutions: 2% CHG, 4% CHG, 20% CHG, Others, Skin Preparations, Surgical, Pharmaceuticals, Others

This research report (Global Chlorhexidine Gluconate Solution Market) investigates and analyzes the current status and outlook for the global market of chlorhexidine gluconate solution over the next five years. It includes information on the overview of the global chlorhexidine gluconate solution market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include 2% CHG, 4% CHG, 20% CHG, and others, while the segments by application cover skin preparations, surgical use, pharmaceuticals, and others. The regional segments calculate the market size of chlorhexidine gluconate solution by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the chlorhexidine gluconate solution market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Eosinophilia Syndrome Drugs

Eosinophilia syndrome drugs global market: Benralizumab, Dasatinib, Dexmethylphenidate hydrochloride, Mepolizumab, Others, Research centers ...

This research report (Global Hypereosinophilic Syndrome Drug Market) investigates and analyzes the current state and outlook for the global market of eosinophilia syndrome drugs over the next five years. It includes information on the overview of the global eosinophilia syndrome drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Benralizumab, Dasatinib, Dexamethasone, Mepolizumab, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for eosinophilia syndrome drugs. It also includes the market share of major companies in the eosinophilia syndrome drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Dyslipidemia Treatment

World Market for Dyslipidemia Treatment: Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Other Drugs, ...

This research report (Global Lipid Disorder Treatment Market) investigates and analyzes the current state and outlook for the global lipid disorder treatment market over the next five years. It includes information on the overview of the global lipid disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include atorvastatin, fluvastatin, rosuvastatin, simvastatin, pravastatin, and other drugs, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for lipid disorder treatment. It also includes the market share of major companies in lipid disorder treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine